In the CGGA RNA-seq set (training set), glioma patients were divided into two groups based on the median expression of DZIP3. Figure 4A, 4B showed that in both all grade and lower grade gliomas, patients in higher DZIP3 expression groups possessed significantly longer survival time than lower expression counterparts (p < 0.0001). Here, DZIP3 is linked to glioma.